The pharmacokinetic properties and relative bioequivalence of two formulations of the antiepileptic Epilimm were compared in a three-period, repeat dose, randomized crossover study in 18 male volunteers. A daily dose of 1000 mg of antiepileptic was given either as twice-daily entericcoated sodium va
A comparison of the anticholinergic effects of two formulations of disopyramide in healthy volunteers
โ Scribed by J. Longmore; J. L. Berry; E. Szabadi; C. M. Bradshaw
- Publisher
- Springer
- Year
- 1990
- Tongue
- English
- Weight
- 607 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Purpose: The purpose of this randomized, crossover study was to compare the bioavailability of a generic and an innovator formulation of nizatidine 300 mg capsules under fasting conditions. ## Methods: Twenty blood samples per period were collected from 20 healthy, arab male volunteers over 16
During steady-state treatment with disopyramide, its main and active metabolite, mono-N-dealkylated disopyramide, was reported to reach concentrations that were equal to or higher than the parent drug in 25% of 70 evaluated patients. This metabolite has been found to have a more pronounced anticholi
CardizemOSR and Bi-TildiemO were both approved in their respective countries on the basis of clinical trials demonstrating efficacy and safety in the treatment of angina pectoris. In this cross-over randomized study, we assessed whether these two sustained-release formulations of diltiazem have equi